论文部分内容阅读
报告５１例Ｂａｎｅｔｔ食管癌的外科治疗效果，占同期食管癌切除总数的１０．２％。患者平均年龄８岁，主要就诊症状为吞咽困难。按ＰＴＮＭ分期，Ⅱ期１８例，占３５．３％；Ⅲ期２９例，占５６．９％；Ⅳ期４例，占７．８％。５１例均行食管部分切除、胃食管重建术。术后３０天死亡率为３．９％，１、２和５年生存率分别为４５．９％、２５．０％和１３．６％。Ⅱ期肿瘤５年生存率（２５．０％）明显高于Ⅲ＋Ⅳ期（４．５％），两者差异有显著意义（Ｐ＜０．０５）。肿瘤直径＜６ｃｍ＜或＞６ｃｍ者，５年生存率分别为２５．０％和０（Ｐ＜０．０５）。结果表明，术后长期生存率与临床分期及肿瘤大小等因素有密切关系。
The surgical treatment of 51 cases of Banett cancers was reported, accounting for 10.2% of the total number of esophageal cancers removed at the same time. The average age of the patients was 8 years old and the main symptom was dysphagia. According to PTNM stage, 18 cases were in stage II, accounting for 35.3%; 29 cases were in stage III, accounting for 56.9%; 4 cases were in stage IV, accounting for 7.8%. All the 51 patients underwent partial esophageal resection and gastroesophageal reconstruction. The 30-day mortality rate was 3.9%, and the 1-, 2-, and 5-year survival rates were 45.9%, 25.0%, and 13.6%, respectively. The 5-year survival rate of stage II tumors (25.0%) was significantly higher than that of stage III+IV (4.5%), and there was a significant difference between them (P<0.05). For patients with tumor diameter <6cm 6cm, 5-year survival rates were 25.0% and 0, respectively (P < 0.05). The results showed that long-term survival after surgery was closely related to factors such as clinical stage and tumor size.